|
2025
|
Invention
|
Plurality of tasquinimod particles and use thereof.
A plurality of particles of tasquinimod in f... |
|
2024
|
Invention
|
Treatment of ocular inflammatory diseases using laquinimod.
Disclosed is a method for treating a... |
|
|
Invention
|
Quinoline carboxamides for use in the treatment of mpn |
|
|
Invention
|
Quinoline carboxamides for use in the treatment of mpn. Described herein is certain quinoline car... |
|
2023
|
Invention
|
Combination of tasquinimod or a pharmaceutically acceptable salt thereof and a pd-1 and/or pd-l1 ... |
|
2022
|
Invention
|
Compounds for treatment of eye diseases associated with excessive vascularisation. The present in... |
|
|
Invention
|
A pharmaceutical product containing tasquinimod and a method for assessing the purity of said pro... |
|
|
Invention
|
Plurality of tasquinimod particles and use thereof. A plurality of particles of tasquinimod in fr... |
|
|
Invention
|
A plurality of tasquinimod particles and use thereof. A plurality of particles of tasquinimod in ... |
|
|
Invention
|
Laquinimod formulation for ocular use.
A pharmaceutical formulation comprising laquinimod or a p... |
|
|
Invention
|
Laquinimod formulation for ocular use. A pharmaceutical formulation comprising laquinimod or a ph... |
|
|
Invention
|
Tasquinimod or a pharmaceutically acceptable salt thereof for use in the treatment of myelodyspla... |
|
2021
|
Invention
|
Tasquinimod or a pharmaceutically acceptable salt thereof for use in combination therapy. A combi... |
|
2019
|
P/S
|
Chemicals for use in industry and science; Chemical products for biotechnological purposes [indus... |
|
2018
|
Invention
|
Quinoline carboxamides for use in the treatment of multiple myeloma. A compound of formula (I)
... |
|
2017
|
Invention
|
N-(heteroaryl)-sulfonamide derivatives useful as s100-inhibitors. A compound of formula (I), or a... |
|
|
Invention
|
Treatment of ocular inflammatory diseases using laquinimod. Disclosed is a method for treating an... |
|
2015
|
Invention
|
Imidazo[2,1-b]thiazole and 5,6-dihydroimidazo[2,1-b]thiazole derivatives useful as s100-inhibitor... |
|
|
Invention
|
Quinoline carboxamides for use in the treatment of leukemia. A compound of formula (I) or a pharm... |
|
|
Invention
|
Quinoline carboxamides for use in the treatment of multiple myeloma. A compound of formula (I), o... |
|
|
Invention
|
Compounds useful as s100-inhibitors. A compound of formula (I) or a pharmaceutically acceptable s... |
|
|
Invention
|
Novel compounds useful as s100-inhibitors. A compound of formula (I) or a pharmaceutically accept... |
|
2013
|
Invention
|
Stable laquinimod preparations. The subject invention provides a pharmaceutical composition compr... |
|
|
Invention
|
Laquinimod for treatment of gaba mediated disorders. This invention provides a method of treating... |
|
|
Invention
|
N-ethyl-n-phenyl-1,2-dihydro-4,5-di-hydroxy-1-methyl-2-oxo-3-quinolinecarboxamide, preparation an... |
|
|
Invention
|
Use of laquinimod for treating crohn's disease patients who failed first-line anti-tnf therapy. T... |
|
2012
|
Invention
|
Deuterium-enriched 4-hydroxy-5-methoxy-n,1-dimethyl-2-oxo-n-[(4-trifluoro-methyl)phenyl]-1,2-dihy... |
|
1998
|
P/S
|
Chemicals used in industry and science, in particular chemical preparations for biochemical and l... |
